Nov 27, 2014 at 22:20 | Source: CNBC-TV18
Nitin Gadkari hopes to get Cabinet nod for changes to the Motor Vehicle Act soon, which he adds would be based on the US and UK norms. He hopes to move amendments to the Act in this session.
Nov 26, 2014 at 14:34 | Source: PTI
Ranbaxy Laboratories had sued USFDA over revoking an approval to sell generic versions of Nexium and Valcyte in the US market.
Nov 25, 2014 at 16:38 | Source: PTI
The funds raised from the issue would be utilised towards repayment of certain borrowings availed by GMR Infrastructure, investment in its subsidiary - GMR Energy Ltd - as well as for general corporate purposes.
Nov 18, 2014 at 19:37 | Source: PTI
The Commission noted that the market shares in terms of installed capacity is 23 percent for Shree Cements and three percent for cement grinding. This will increase the market share of Shree Cements to 26 percent post the combination.
Nov 17, 2014 at 15:04 | Source: Moneycontrol.com
Lower expenses & higher other income drove the realty major's net profit up 35.5 per cent increase to Rs 57.86 crore in the quarter ended September 2014. Total income during the period declined 31.32 percent to Rs 304.84 crore from Rs 443.90 crore in the same quarter in FY14.
Nov 13, 2014 at 18:05 | Source: CNBC-TV18
These RPTs signed in June 2013 few weeks before it entered into agreement with Diageo for stake sale were enforced by the company without seeking shareholder nod till now.
Nov 12, 2014 at 14:03 | Source: PTI
"IPO is being discussed and being reviewed by finance ministry. We expect to get their response in a month," UTI MF MD Leo Puri said.
Nov 12, 2014 at 13:55 | Source: Moneycontrol.com
The board has also approved hiving-off of the running business of battery division of the company, located at Pant Nagar, Uttrakhand to a prospective joint venture between Minda Industries and Panasonic Corporation.
Nov 12, 2014 at 12:51 | Source: CNBC-TV18
O the issue of the companys share buyback, Akhil Gupta, vice chairman, Bharti Enterprises says he expects the government or the Ministry of Corporate Affairs to take up the issue soon.
Nov 12, 2014 at 08:34 | Source: Reuters
India's USD 15 billion pharmaceutical industry, which has been hit by a spate of regulatory sanctions in the past year due to concerns about production processes, supplies about 40 percent of generic and over-the-counter drugs to the United States.